VenoStent - About the company
VenoStent is a series A company based in Nashville (United States), founded in 2017. It operates as a Developer of a shape memory polymer stent for vascular surgery. VenoStent has raised $33.4M in funding from investors like Good Growth Capital, IAG Capital Partners and Y Combinator. The company has 7 active competitors, including 2 funded and 2 that have exited. Its top competitors include companies like Invizius, Redsense Medical and Doto Medical.
Company Details
Developer of a shape memory polymer stent for vascular surgery. The SelfWrap, is an external stent, used for venous access in hemodialysis patients. The stent, is a polymer wrap, provides a mechanical support and reduces vein collapse, at the point of surgery, by promoting vein growth in dialysis patients.
- Website
- www.venostent.com/
- Email ID
- *****@venostent.com
Key Metrics
Founded Year
2017
Location
Nashville, United States
Stage
Series A
Total Funding
$33.4M in 13 rounds
Latest Funding Round
Investors
Ranked
2nd among 7 active competitors
Employee Count
33 as on Apr 30, 2026
Legal entities associated with VenoStent
VenoStent is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
VenoStent, Inc CIN: 822965768 , United States, Active | Dec 31, 2016 | - | - | - |
Sign up to download VenoStent's company profile
VenoStent's funding and investors
VenoStent has raised a total funding of $33.4M over 13 rounds. Its first funding round was on Mar 07, 2018. VenoStent has 22 institutional investors.
Here is the list of recent funding rounds of VenoStent:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 10, 2026 | 1405983 | Series A | 2013081 | 1106270 | 1108018 | 5396976 |
May 15, 2025 | 6092183 | Grant (prize money) | 9849132 | 3924830 | 6287277 | |
Apr 24, 2025 | 5140251 | Grant (prize money) | 2434588 | 6158280 | 9334842 |
View details of VenoStent's funding rounds and investors
VenoStent's founders and board of directors
Founder? Claim ProfileVenoStent's employee count trend
VenoStent has 33 employees as of Apr 26. Here is VenoStent's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
VenoStent's Competitors and alternates
Top competitors of VenoStent include Invizius, Redsense Medical and Doto Medical. Here is the list of Top 10 competitors of VenoStent, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Invizius 2018, Edinburgh (United Kingdom), Series A | Developer of priming solutions for hemodialyzers | $13.1M | 57/100 | |
2nd | VenoStent 2017, Nashville (United States), Series A | Developer of a shape memory polymer stent for vascular surgery | $33.4M | 49/100 | |
3rd | Redsense Medical 2006, Halmstad (Sweden), Public | Blood loss detection device | - | - | 41/100 |
4th | Doto Medical 2023, Wrocław (Poland), Unfunded | Developer of Aptamer-driven solutions for chronic kidney diseases | - | - | 38/100 |
5th | Renal Solutions 2000, Warrendale (United States), Acquired | Roots blower and vacuum pump manufacturer with 15 years experience | $34.5M | 35/100 | |
6th | Peace and Quiet Care 2017, Manchester (United Kingdom), Deadpooled | Developer of renal dialysis machine with sound proof box | - | - | 22/100 |
7th | Health Line International Corporation 2004, Salt Lake City (United States), Funding Raised | Vascular access catheter manufacturer providing infusion therapy and infection control devices | - | 20/100 | |
8th | Medcomp 1978, Harleysville (United States), Unfunded | Manufacturer of vascular access devices and accessories. This company develops, manufactures, and markets a wide array of products for interventional medicine and dialysis, including catheters for long-term and short-term hemodialysis, PICC lines, midline catheters, ports, and peritoneal dialysis accessories. The product portfolio also encompasses related items such as catheter lock solutions, drainage systems, and various introducer needles and guidewires. The company focuses on providing solutions that meet the clinical needs of the medical industry, emphasizing patient comfort and ease of use. | - | - | 16/100 |
9th | OAS Project 2016, Madrid (Spain), Deadpooled | Developer an accessory device for dialysis | - | - | 15/100 |
10th | Oxyless 2010, London (United Kingdom), Deadpooled | Developed a bloodline for dialysis | - | - | 14/100 |
Looking for more details on VenoStent's competitors? Click here to see the top ones
VenoStent's Investments and acquisitions
VenoStent has made no investments or acquisitions yet.
News related to VenoStent
•
•
VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US TrialACCESSWIRE•Jul 31, 2023•VenoStent, Good Growth Capital, IAG Capital Partners, TMC Venture Fund and 11 others
•
VenoStent Raises $2.3M in Seed FundingFinSMEs•Feb 23, 2021•VenoStent, Creative Ventures, IAG Capital Partners, C3 Ventures and 5 others
•
•
VenoStent has a new technology to improve outcomes for dialysis patientsTechCrunch+•Aug 09, 2020•VenoStent
Are you a Founder ?
FAQs about VenoStent
Explore our recently published companies
- Maxwellshouseofmusic - Unfunded company
- Altrisk - 1997 founded, Unfunded company
- Snoozer - Una based, 1995 founded, Public company
- Seatingsymposium - Unfunded company
- FTA HSRP Solutions - Gandhinagar based, 2012 founded, Unfunded company
- Vibrant TMT - Ahmedabad based, 2012 founded, Unfunded company
